Medical Marijuana, Inc. subsidiary HempMeds® Brasil is having a fantastic year in 2017, and the company is looking to build on that success with its second major event of the year.
After an event in Rio de Janeiro organized in early April, it was time for HempMeds® Brasil to bring word of the benefits of CBD to the city of São Paulo. The company will host their first event in the city on August 15th.
HempMeds® Brasil will use the upcoming event to personally introduce the company to the local medical community. The company will connect with physicians in the region who are interested in prescribing cannabidiol as a treatment option.
Founded in 2014, HempMeds® Brasil is led and operated by Brazilians and was originally founded to work side by side with patients hoping to access CBD oil. Now, the company distributes Real Scientific Hemp Oil™ (RSHO™) products as prescription medications to families throughout the country.
Confirmed speakers at the event include pioneers in the CBD oil space, including Dr. Saúl Garza Morales, who specializes in neuropediatrics, and Dr. Stuart Titus, CEO of Medical Marijuana Inc., the parent company of HempMeds® Brazil.
Dr. Saúl Garza Morales is a specialist in Pediatric Neurology. He has more than 25 years of experience in public health institutions and has published more than 70 scientific articles on neurodevelopmental development and childhood epilepsy.
In 2012, Dr. Garza was the winner of the annual Pharmaceutical Research Award for the clinical development of a new molecule for the treatment of epilepsy.
At the Brazil event, Dr. Garza will present his recently published study of the CBD oil RSHO-X™, in the treatment of refractory epilepsy – specifically Lennox-Gastaut Syndrome. He will also address his observations and experience with CBD in the control of Autism and the latest news regarding CBD research.
Also scheduled to speak is Dr. Stuart Titus, CEO of Medical Marijuana, Inc. and an icon of the cannabis industry.
Dr. Titus is associated with the American Academy of Pain Management and the American Association of Integrative Medicine and worked as a physiotherapist for more than fifteen years managing specialized clinics in the treatment of pain and injury rehabilitation, treating more than 40,000 patients.
“Our relationship with Brazil is thriving every day, and our goal is to contribute to health professionals to encourage the treatment of pathologies for which there is still no cure, “says Dr. Titus.
Dr. Stuart Titus will discuss the impact that CBD can have on patients’ quality of life, including the biology of the endocannabinoid system, the benefits of hemp as a source of cannabinoids, and the CBD oil import process in Brazil.
August 15 at 6:00 PM
Marriott Renaissance Hotel, São Paulo
Alameda Santos 2233, 01419-002
HempMeds® Brasil continues to work in every possible way to improve its patient services, facilitate access to CBD, and help those who need it navigate the authorization and importation process. Patients in Brazil can contact HempMeds® Brasil to get answers to all your CBD questions. If you are a doctor, register for HempMeds® Brasil’s next event using the contact information below.
RJ 21 4042-2095 | SP 11 4200-0618
Monday to Friday from 11:00 a.m. to 11:00 p.m.
Stay up-to-date with Medical Marijuana, Inc.’s entire portfolio of companies by following our news feed.